Monogram Orthopaedics, Inc. (MGRM) Stock Overview
Explore Monogram Orthopaedics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Monogram Orthopaedics, Inc. (MGRM)
Key Financials
Key Financials
Market Cap
243.8M
P/E Ratio
-23.42
EPS (TTM)
$-0.50
ROE
-0.85%
MGRM Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Monogram Orthopaedics, Inc. (NASDAQ: MGRM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Monogram Orthopaedics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MGRM on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $10.24 for the NASDAQ listing.
Key metrics behind Monogram Orthopaedics, Inc.'s NASDAQ-traded stock include a P/E ratio of -23.42 and a market capitalization of 243.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MGRM on the NASDAQ.